QA: Seelos Therapeutics INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2016_Seelos_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001017491, Seelos Therapeutics INC

  xvar xval
0 AssetsCurrent 6,291,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,290,000
3 remainder_Assets 274,000
4 LiabilitiesCurrent 15,758,000
5 LiabilitiesNoncurrent 200,000
6 remainder_Liabilities 1,841,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,162,936
9 ResearchAndDevelopmentExpense 16,511,680
10 remainder_Expenses 778,273
11 remainder_Revenues 6,846,839
12 remainder_NetIncome 1,818,477
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 7,855,000
1 Liabilities 17,799,000
2 Expenses 27,452,889
3 Revenues 6,846,839
4 StockholdersEquity -9,944,000
5 NetIncome -18,787,573
6 ComprehensiveNetIncome -18,787,573
7 BaseVar 30,886,102
8 EconomicCapitalRatiobeforeLimitedLiability -3.15
9 EconomicCapitalRatio 0.636

Edgar->Model Mapping

Feature Distribution

Change over Time